News archive

31.08.10
Lab21 launches new commercial companion diagnostic service for HIV tropism in UK →
Lab21 Corporate News Item 61

26.08.10
Lab21 licences pharmacogenetic IP for CES-1 from MUSC →
Lab21 Corporate News Item 61

01.06.10
Lab21 achieves first product registration in China →
Lab21 Corporate News Item 61

24.05.10
Lab21 and Virco partner to offer UK-based HIV-1 genotyping services →
Lab21 Corporate News Item 60

18.12.09
Lab21 acquires US nanotechnology company and establishes Lab21 Inc. in South Carolina →
Lab21 Corporate News Item 59

26.11.09
Lab21 acquires personalised medicine diagnostic services business →
Lab21 Corporate News Item 59

17.11.09
Lab21 launches new high sensitivity immunodiagnostic system for CMV antibody detection →
Lab21 Corporate News Item 58

04.08.09
Lab21 Ltd to Provide AdnaGen’s CE-Marked System for the Detection and Analysis of Circulating Tumor Cells (CTCs) in the United Kingdom and Ireland. →
Lab21 Corporate News Item 57

21.07.09
Lab21 announces publication of syphilis diagnostic patent →
Lab21 Corporate News Item 56

22.06.09
Lab21 expands its predisposition oncology service portfolio with A NEW TEST TO DETERMINE SMOKERS’ LUNG CANCER RISK →
Lab21 Corporate News Item 55

16.06.09
Lab21 partners with Innogenetics to build comprehensive HCV drug resistance IP portfolio →
Lab21 Corporate News Item 54

27.05.09
Lab21 expands oncology portfolio with 5-FU personalised chemotherapy management service →
Lab21 Corporate News Item 53

20.05.09
Lab21 acquires Plasmatec Laboratory Products from Axis-Shield →
Lab21 Corporate News Item 52

24.03.09
Lab21’s NP Tech division gains CPA accreditation →
Lab21 Corporate News Item 52

17.03.09
Lab21 raises a further £1.3m and Dr Kai Deusch joins the Board →
Lab21 Corporate News Item 51

03.03.09
Lab21 Acquires Biotec Laboratories →
Lab21 Corporate News Item 50

27.01.09
Lab 21 and Breasthealth UK form partnership for breast health management →
Lab21 Corporate News Item 49

23.12.08
Lab21 successfully closes funding round of £2.2m →
Lab21 Corporate News Item 48

16.12.08
Lab21 launches new 3 day service to identify Fungal Pneumonia →
Lab21 Corporate News Item 47

07.11.08
Lab21 Expands International Business with Launch into India with a Million Dollar Syphilis Testing Agreement →
Lab21 Corporate News Item 46

17.10.08
Lab21 spins out environmental monitoring business to Cogent Environmental Ltd →
Lab21 Corporate News Item 45

October 2008
Lab21 to market deCODE BreastCancer™, a Genetic Test to Screen for Risk of the Most Common Forms of Breast Cancer →
Lab21 Corporate News Item 44

September 2008
Lab21 expands its range of cardiovascular genetic tests with Clinical Data, Inc. →
Lab21 Corporate News Item 43

August 2008
Lab21 to market deCODE tests for assessing risk of common diseases →
Lab21 Corporate News Item 42

July 2008
Lab21 expands companion diagnostic cancer testing service internationally →
Lab21 Corporate News Item 41

June 2008
Lab21 expands cancer gene testing service →
Lab21 Corporate News Item 40

June 2008
Lab 21 Environmental helping to provide safe drinking water following Chinese earthquake →
Lab21 Corporate News Item 39

March 2008
Lab21 acquires NPTech Ltd and appoints corporate advisors for European M&A activity →
Lab21 Corporate News Item 38

March 2008
Amgen and Lab21 in Partnership Agreement for New Cancer Therapy Test →
Lab21 Corporate News Item 37

February 2008
Lab21 signs a license with Celera for one of the first diagnostic tests for cirrhosis risk in hepatitis C patients →
Lab21 Corporate News Item 36

January 2008
Lab21 launches cancer gene testing service →
Lab21 Corporate News Item 35

January 2008
Lab21 Spearheads Introduction of improved Diagnostic Assays for Healthcare and Environmental Management →
Lab21 Corporate News Item 34

November 2007
Lab21 appoints new Chief Executive Officer →
Lab21 Corporate News Item 33

October 2007
Ark outlicenses marketing rights for Ox-LDL heart attack risk test kit to Lab21 →
Lab21 Corporate News Item 32

October 2007
Lab21 completes partnership deal with Monogram Biosciences to enable launch of HIV Trofile™ assay in UK →
Lab21 Corporate News Item 31

August 2007
New syphilis test provides quicker and easier diagnosis →
Lab21 Corporate News Item 30

June 2007
Genetic Tests for Thrombotic Disease Could Save Lives and Reduce Healthcare Costs →
Lab21 Corporate News Item 29

April 2007
Lab21 announces appointment of new Chief Financial Officer →
Lab21 Corporate News Item 28

March 2007
One day diagnostic test for respiratory diseases launched →
Lab21 Corporate News Item 27

December 2006
Clinical Data and Lab21 Launch Cardiac Channelopathy Genetic Test in United Kingdom & Ireland →
Lab21 Corporate News Item 26

December 2006
Lab21 First UK Outlet for New 20 Respiratory Virus Panel Diagnostic Assay →
Lab21 Corporate News Item 25

August 2006
Lab21 collaborates with leading oncology managed care provider →
Lab21 Corporate News Item 24

July 2006
Lab21 begins worldwide survey of Hepatitis C NS3 diversity for leading Pharma Company →
Lab21 Corporate News Item 23

May 2006
Lab21 signs exclusive agreement with the Mole Clinic →
Lab21 Corporate News Item 22

April 2006
Lab21 takes the lead in Avian flu testing →
Lab21 Corporate News Item 21

March 2006
Interferon neutralising antibodies in patients with MS →
Lab21 Corporate News Item 20

March 2006
Lab21 supports NHS for breast and ovarian cancer testing →
Lab21 Corporate News Item 19

January 2006
Antiviral Services secure multiple Pharmaceutical and Biotech contracts →
Lab21 Corporate News Item 18

December 2005
Lab21 and Myriad enter into exclusive agreement for oncology diagnostics →
Lab21 Corporate News Item 17

November 2005
Lab21 and Seryx enter into exclusive agreement →
Lab21 Corporate News Item 16

November 2005
Agreement with Amsterdam Medical Centre expands viral expertise →
Lab21 Corporate News Item 15

September 2005
Lab21 opens leading edge lab facility on Cambridge Science Park →
Lab21 Corporate News Item 14

August 2005
Lab21 acquires IP for HCV resistance diagnostics →
Lab21 Corporate News Item 13

June 2005
Lab21 introduces revolutionary multiplex technology for genetic
testing →
Lab21 Corporate News Item 12

April 2005
A proven safe alternative to liver biopsy →
Lab21 Corporate News Item 11

April 2005
Corporate offices open →
Lab21 Corporate News Item 10